Health and Sustainability Innovator Greg Horn Joins Flagship Ventures

Health and Sustainability Innovator Greg Horn Joins Flagship Ventures

June 28, 2012

CAMBRIDGE, Mass.--()--Flagship Ventures, a leading venture capital and venture creation firm focused on healthcare and sustainability, today announced the appointment of Greg Horn as a Venture Partner. Mr.

Receptos Co-Publishes Highest Resolution G-Protein Coupled Receptor Structure to Date in Science

Receptos Co-Publishes Highest Resolution G-Protein Coupled Receptor Structure to Date in Science

July 12, 2012

-Publication of a 1.8 Angstrom Resolution Structure for the Human Adenosine 2A Receptor is a Powerful Endorsement of Receptos Proprietary G-Protein Coupled Receptor Technology Platform-

Health and Sustainability Innovator Greg Horn Joins Flagship Ventures

Health and Sustainability Innovator Greg Horn Joins Flagship Ventures

June 28, 2012

CAMBRIDGE, Mass., Jun 28, 2012 (BUSINESS WIRE) -- Flagship Ventures, a leading venture capital and venture creation firm focused on healthcare and sustainability, today announced the appointment of Greg Horn as a Venture Partner. Mr.

Affinnova is Fastest-Rising Company on Honomichl Top 50

Affinnova is Fastest-Rising Company on Honomichl Top 50

June 20, 2012

Company climbs from #49 to #38 on annual ranking of research firms

BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Atherotech Diagnostics Lab

BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Atherotech Diagnostics Lab

June 18, 2012

 

RELATED QUOTES

Symbol Price  

T2 Biosystems Presents Data on Novel Method for Endotoxin Detection at ASM 2012

T2 Biosystems Presents Data on Novel Method for Endotoxin Detection at ASM 2012

June 18, 2012

 

LS9 Opens Florida Demonstration Facility for Renewable Products

LS9 Opens Florida Demonstration Facility for Renewable Products

June 12, 2012

 Grand Opening Celebration With State and Local Officials

Seventh Sense Biosystems Appoints President and CEO and Closes $10 Million Series-A Financing

Seventh Sense Biosystems Appoints President and CEO and Closes $10 Million Series-A Financing

June 13, 2012
Wed Jun 13, 2012 8:15am EDT

Seventh Sense Biosystems Appoints President and CEO and Closes $10 Million Series-A Financing

Avedro Announces CE Mark for its Newest Riboflavin Formulations

Avedro Announces CE Mark for its Newest Riboflavin Formulations

June 12, 2012

The First Complete Family of Cross-linking Products

Ring My BEL: Selventa Releases Biological Expression Language

Ring My BEL: Selventa Releases Biological Expression Language

May 23, 2012

By Kevin Davies

May 23, 2012 | With a recent rebranding and evolving business model, Selventa—the company formerly known as Genstruct—has decided to release a key knowledge engineering asset to the scientific community.